Lantheus Holdings, Inc Stock Prediction
AI-powered sentiment analysis and prediction trends for LNTH, updated each market day.
LNTH AI Sentiment
AI predicts Lantheus Holdings, Inc stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Lantheus Holdings, Inc
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Sector
Exchange
Market Cap
$5,301,304,636
Cap Tier
Employees
1,193
Headquarters
NORTH BILLERICA, MA
Listed Since
June 25, 2015
Website
LNTH Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
LNTH Volatility
Lantheus Holdings, Inc has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
